Alex Levit - 19 Oct 2021 Form 3 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Legal Officer, Corp. Sec
Signature
/s/ Tyler J. Vivian, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
19 Oct 2021
Transactions value $
$0
Form type
3
Filing time
19 Oct 2021, 18:08:27 UTC
Next filing
25 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTX Stock Option (right to buy) 19 Oct 2021 Common Stock 52.8K $4.94 Direct F1
holding CNTX Stock Option (right to buy) 19 Oct 2021 Common Stock 833 $5.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests each month (1/36 each month) from the date of the grant, April 30, 2021.
F2 Fully vested.